发明名称 Insulin and IGF-1 receptor agonists and antagonists
摘要 <p>Peptide sequences capable of binding to insulin and/or insulin-like growth factor receptors with either agonist or antagonist activity and identified from various peptide libraries are disclosed. This invention also identifies at least two different binding sites which are present on insulin and insulin-like growth factor receptors which selectively bind the peptides of this invention. As agonists, certain of the peptides of this invention may be useful for development as therapeutics to supplement or replace endogenous peptide hormones. The antagonists may also be developed as therapeutics. In one embodiment, the receptor-binding peptides comprise the core motive B6: X 6 X 7 X 8 X 9 X 10 X 11 X 12 X 13 wherein X 6 and X 7 are aromatic, and X 10 and X 13 are hydrophobic residues.</p>
申请公布号 EP2368902(A2) 申请公布日期 2011.09.28
申请号 EP20100186251 申请日期 2000.03.29
申请人 DGI BIO TECHNOLOGIES LLC;NOVO NORDISK A/S 发明人 BEASLEY, JAMES;BLUME, ARTHUR J.;SCHAEFFER, LAUGE;PILLUTLA, RENUKA;BRANDT, JAKOB;BRISSETTE, RENEE;SPETZLER, JANE;CHENG, WEIQING;OESTERGAARD, SOEREN;MANDECKI, WLODEK S.;HANSEN, PER HERTZ;RAVERA, MARK;HSIAO, KU-CHAUN
分类号 C07K7/08;G01N33/50;A61K35/76;A61K38/00;A61K48/00;A61P3/10;A61P35/00;A61P43/00;C07K1/04;C07K14/00;C12N5/10;C12N15/09;C40B30/00;C40B40/02;C40B50/06;G01N33/15;G01N33/74 主分类号 C07K7/08
代理机构 代理人
主权项
地址